H.R. 1107, PRC is Not a Developing Country Act

As ordered reported by the House Committee on Foreign Affairs on February 28, 2023

H.R. 803, Pressure Regulatory Organizations to End Chinese Threats to Taiwan Act

As ordered reported by the House Committee on Financial Services on February 28, 2023

H.R. 1076, Preventing the Financing of Illegal Synthetic Drugs Act

As ordered reported by the House Committee on Financial Services on February 28, 2023

Options for Reducing the Deficit

CBO’s Director, Phillip Swagel, uses the agency’s latest report on budget options to illustrate ways to reduce the deficit.

S. 185, Native American Direct Loan Improvement Act of 2023

As ordered reported by the Senate Committee on Veterans’ Affairs on February 16, 2023

S. 619, COVID-19 Origin Act of 2023

As passed by the Senate on March 1, 2023

H.R. 140, Protecting Speech from Government Interference Act

As ordered reported by the House Committee on Oversight and Accountability on February 28, 2023

Legislation considered under suspension of the Rules of the House of Representatives during the week of March 6, 2023

The Majority Leader of the House of Representatives announces bills that will be considered under suspension of the rules in that chamber. CBO estimates the effects of those bills on direct spending and revenues.

S. 326, VA Medicinal Cannabis Research Act of 2023

As ordered reported by the Senate Committee on Veterans’ Affairs on February 16, 2023

CBO’s Waterfall Model for Projecting Discretionary Spending, March 2023

CBO's interactive tool allows users to simulate the agency's process for projecting discretionary budget authority and outlays for different types of spending over the course of 10 years.